Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 86 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 04/02/03
End: 01/01/26
Due: 01/01/27
Development and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple Sclerosis
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 11/23/24
Due: 11/23/25
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 06/09/24
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 04/01/17
End: 04/01/18
Due: 04/01/19
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 11/06/16
End: 01/07/19
Due: 01/07/20
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 11/08/23
End: 03/15/24
Due: 03/15/25
Phase: N/A
Priority: Normal
Start: 07/20/18
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 04/05/21
Due: 04/05/22
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 05/05/25
End: 12/30/26
Due: 12/30/27
Phase: N/A
Priority: Normal
Start: 05/31/20
End: 10/20/20
Due: 10/20/21
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 11/21/20
End: 03/01/23
Due: 03/01/24
Phase: N/A
Priority: Normal
Start: 04/10/22
End: 09/18/22
Due: 09/18/23